At baseline, expression of CD158a on total γδpos T cells (Supplementary Figure 3B) close to be significant in TB-IRIS patients vs. non-IRIS[median (25–75% IQR): 12.40 (7.78–19.60) vs. 6.30 (2.94–14.50), p = 0.05]; however, CD158a expression on γδpos T cells was significantly higher for TB-IRIS patients than HD [median (25–75% IQR): 4.45 (1.68–8.30)] (p = 0.001). Here, KIR2DL1 is linked to tuberculosis.